noon glp 1 Noom Launches GLP-1 Microdosing for Longevity or prevent any disease. πA new approach to weight
Description
These mechanisms are supported in animal models and early-phase human studies, but more large-scale trials are needed to confirm their real-world relevance
doi: 10.1056/EVIDoa2200014
The dominance of GLP-1 and oncology products clearly shows where global demand is accelerating
Many patients use this program alongside hormone therapy, mental health care, or IV nutrient support
Because we just dont know yet exactly what the long-term outcomes are for people who become pregnant while taking these medications. One early study suggested that using GLP-1 agonists during the first trimester didnt harm fetal development
